Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Regina-Veronicka Kalaydina, Komal Bajwa, Bessi Qorri, Alexandria Decarlo & Myron R Szewczuk. (2018) Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International Journal of Nanomedicine 13, pages 4727-4745.
Read now
Read now
Articles from other publishers (19)
Yuliang Feng, Liuyang Cai, Martin Pook, Feng Liu, Chao-Hui Chang, Mai Abdel Mouti, Reshma Nibhani, Stefania Militi, James Dunford, Martin Philpott, Yanbo Fan, Guo-Chang Fan, Qi Liu, Jun Qi, Cheng Wang, Wanzi Hong, Hannah Morgan, Mingyang Wang, Sakthivel Sadayappan, Anil G. Jegga, Udo Oppermann, Yigang Wang, Wei Huang, Lei Jiang & Siim Pauklin. (2023) BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma. Gastroenterology.
Crossref
Crossref
Jingjing Zhang, Luya Li, Jintuo Yin, Xidong Zhang, Ying Zheng & Rui Feng. (2023) Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy. BMC Pharmacology and Toxicology 24:1.
Crossref
Crossref
Jill P. Smith, Wenqiang Chen, Narayan Shivapurkar, Monica Gerber, Robin D. Tucker, Bhaskar Kallakury, Siva Sai Krishna Dasa, Ruvanthi N. Kularatne & Stephan T. Stern. (2023) Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression. International Journal of Molecular Sciences 24:1, pages 752.
Crossref
Crossref
Fengjiao Li, Chong He, Hanming Yao, Yue Zhao, Xijiu Ye, Shurui Zhou, Jinmao Zou, Yaqing Li, Jiajia Li, Shaojie Chen, Fanghai Han, Kaihong Huang, Guoda Lian & Shangxiang Chen. (2023) Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification. Pharmacological Research 187, pages 106555.
Crossref
Crossref
Junge Chen, Fengqiang Cao, Yang Cao, Shujin Wei, Xiurui Zhu & Wanli Xing. (2022) Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel. Journal of Biomedical Nanotechnology 18:4, pages 1075-1083.
Crossref
Crossref
Candace M. Day, Martin J. Sweetman & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
119
162
.
Ming-Hsien Chan, Yung-Chieh Chan, Ru-Shi Liu & Michael Hsiao. (2020) A selective drug delivery system based on phospholipid-type nanobubbles for lung cancer therapy. Nanomedicine 15:27, pages 2689-2705.
Crossref
Crossref
Kanchan Chauhan, Prakhar Sengar, Karla Juarez-Moreno, Gustavo A. Hirata & Rafael Vazquez-Duhalt. (2020) Camouflaged, activatable and therapeutic tandem bionanoreactors for breast cancer theranosis. Journal of Colloid and Interface Science 580, pages 365-376.
Crossref
Crossref
Tala M. Abu Samaan, Marek Samec, Alena Liskova, Peter Kubatka & Dietrich Büsselberg. (2019) Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 9:12, pages 789.
Crossref
Crossref
Huiqin Liu, Mengnan Sun, Zhengsheng Liu, Chao Kong, Weijian Kong, Junxiao Ye, Jianan Gong, David C.S. Huang & Feng Qian. (2019) KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs. Journal of Controlled Release 296, pages 40-53.
Crossref
Crossref
Sara Nidal Abed, Pran Kishore Deb, Hiba Salim Surchi, Sarah Falah Kokaz, Saadh Mohamed Jamal, Shantanu Bandopadhyay & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery
685
731
.
Taojian Fan, Yansheng Zhou, Meng Qiu & Han Zhang. (2018) Black phosphorus: A novel nanoplatform with potential in the field of bio-photonic nanomedicine. Journal of Innovative Optical Health Sciences 11:06.
Crossref
Crossref
J. P. Little, G. J. Pettet, D. W. Hutmacher & D. Loessner. (2018) SpheroidSim—Preliminary evaluation of a new computational tool to predict the influence of cell cycle time and phase fraction on spheroid growth. Biotechnology Progress 34:6, pages 1335-1343.
Crossref
Crossref
Anna-Laura Kretz, Silvia von Karstedt, Andreas Hillenbrand, Doris Henne-Bruns, Uwe Knippschild, Anna Trauzold & Johannes Lemke. (2018) Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy. Cancers 10:3, pages 77.
Crossref
Crossref
Lei Miao, Shutao Guo, C. Michael Lin, Qi Liu & Leaf Huang. (2017) Nanoformulations for combination or cascade anticancer therapy. Advanced Drug Delivery Reviews 115, pages 3-22.
Crossref
Crossref
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari & Ali Zandi-Karimi. (2017) Nanotechnology for delivery of gemcitabine to treat pancreatic cancer. Biomedicine & Pharmacotherapy 88, pages 635-643.
Crossref
Crossref
Robert M. Hoffman, Yukihiko Hiroshima, Takashi Murakami & Takuya Murata. 2017. Patient-Derived Mouse Models of Cancer. Patient-Derived Mouse Models of Cancer
125
132
.
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook & Scott E. McNeil. (2016) Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nature Reviews Clinical Oncology 13:12, pages 750-765.
Crossref
Crossref
Behdokht Bahrami, Mousa Mohammadnia-Afrouzi, Peyman Bakhshaei, Yaghoub Yazdani, Ghasem Ghalamfarsa, Mehdi Yousefi, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mohammad Hojjat-Farsangi. (2015) Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. Tumor Biology 36:8, pages 5727-5742.
Crossref
Crossref